Company / Net Income
Relay Therapeutics, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$276.5M
FY2025
5-year range
-$342.0M / -$52.4M
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
#173 of 216
Health Care
What the data says
Relay Therapeutics, Inc.'s net income of -$276M is lower than 80% of companies in the Health Care sector (FY2025). Improved from -$342M to -$276M over the past 2 years.
Based on SEC 10-K filings.
-$276M in FY2025.
Improved from -$342M to -$276M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 216This company -$276.5M Sector average $454.1M
▼
-160.9% below sector average
Key checks
Key Insights
- In FY2025, net income increased 18.1% year-over-year.
- Ranks #173 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2022.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$276.5M | +18.1% |
| FY2024 | -$337.7M | +1.2% |
| FY2023 | -$342.0M | -552.5% |
| FY2022 | -$52.4M | +30.4% |
| FY2021 | -$75.3M | +0.0% |
| FY2020 | -$75.3M | +0.0% |
| FY2019 | -$75.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026